About Clintelligence

AI-powered protocol intelligence platform designed to help sponsors design better clinical trials from the start.

Our Mission

Better protocol design leads to fewer failed trials, which means faster treatments for patients. We're building the intelligence layer that helps clinical trial sponsors make evidence-based design decisions before they start their studies.

The Problem

  • • 90% of drugs fail clinical trials
  • • 30-40% of failures due to poor protocol design
  • • Each amendment costs $141K-$535K
  • • 57% of protocols require substantial amendments

Our Solution

  • • AI analysis against 566K+ historical trials
  • • Instant protocol optimization recommendations
  • • Risk prediction before trial starts
  • • Evidence-based eligibility optimization

Ready to optimize your protocol?

Get instant AI-powered insights for your clinical trial design.

Start Analysis